109 Division OF Hem/Onc: Oncology Board Review Conference: "Renal" (120122)

Dallas, TX US
December 1, 2022
Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
12/01/2022
Course expires: 
12/01/2022
Event starts: 
12/01/2022 - 7:30am CST
Event ends: 
12/01/2022 - 8:30am CST
Cost:
$0.00
Part of: 
109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE 2022
Add to calendar: 
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Speaker(s)

Hans Hammers, MD PhD

has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with Armo Biosciences;.
has a financial relationship (Independent contractor) with Surface Oncology;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Corvus;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Independent contractor) with BMS;.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.